Zacks Investment Research upgraded shares of Trupanion Inc (NYSE:TRUP) from a hold rating to a buy rating in a research note issued to investors on Wednesday morning. They currently have $29.00 price objective on the financial services provider’s stock.

According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “

A number of other analysts also recently issued reports on the stock. BidaskClub downgraded shares of Trupanion from a hold rating to a sell rating in a report on Thursday, September 7th. Cowen and Company reaffirmed a buy rating and set a $19.00 price objective on shares of Trupanion in a research report on Friday, July 14th. Northland Securities set a $23.00 price objective on shares of Trupanion and gave the stock a buy rating in a research report on Thursday, July 6th. TheStreet raised shares of Trupanion from a d rating to a c- rating in a research report on Monday, July 17th. Finally, Royal Bank Of Canada increased their price objective on shares of Trupanion from $19.00 to $26.00 and gave the stock an outperform rating in a research report on Wednesday, August 2nd. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Trupanion has a consensus rating of Buy and a consensus price target of $26.50.

Shares of Trupanion (TRUP) traded down 3.39% on Wednesday, hitting $27.07. The company’s stock had a trading volume of 190,737 shares. The firm’s market cap is $811.96 million. Trupanion has a one year low of $13.71 and a one year high of $28.30. The stock has a 50-day moving average price of $23.32 and a 200 day moving average price of $20.20.

Trupanion (NYSE:TRUP) last announced its quarterly earnings results on Tuesday, August 1st. The financial services provider reported ($0.02) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.03) by $0.01. The business had revenue of $58.30 million during the quarter, compared to the consensus estimate of $57.58 million. Trupanion had a net margin of 0.71% and a return on equity of 3.57%. The business’s revenue was up 27.3% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.03) EPS. Equities research analysts predict that Trupanion will post ($0.09) EPS for the current year.

TRADEMARK VIOLATION WARNING: “Trupanion Inc (TRUP) Upgraded to “Buy” at Zacks Investment Research” was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://www.watchlistnews.com/trupanion-inc-trup-upgraded-to-buy-at-zacks-investment-research/1610915.html.

In other Trupanion news, insider Margaret Tooth sold 4,500 shares of the firm’s stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $23.00, for a total value of $103,500.00. Following the completion of the transaction, the insider now owns 4,502 shares of the company’s stock, valued at approximately $103,546. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Howard E. Rubin sold 100,000 shares of the firm’s stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $25.90, for a total transaction of $2,590,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 150,552 shares of company stock valued at $3,741,754 in the last ninety days.

A number of hedge funds have recently modified their holdings of TRUP. American International Group Inc. boosted its position in Trupanion by 7.1% in the 1st quarter. American International Group Inc. now owns 8,864 shares of the financial services provider’s stock valued at $126,000 after buying an additional 588 shares during the period. Dynamic Technology Lab Private Ltd purchased a new position in Trupanion in the 1st quarter valued at approximately $194,000. Bank of Montreal Can boosted its position in Trupanion by 309.2% in the 2nd quarter. Bank of Montreal Can now owns 9,044 shares of the financial services provider’s stock valued at $201,000 after buying an additional 6,834 shares during the period. Voya Investment Management LLC purchased a new position in Trupanion in the 2nd quarter valued at approximately $215,000. Finally, Alliancebernstein L.P. boosted its position in Trupanion by 1.2% in the 1st quarter. Alliancebernstein L.P. now owns 16,700 shares of the financial services provider’s stock valued at $237,000 after buying an additional 200 shares during the period.

About Trupanion

Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.

Analyst Recommendations for Trupanion (NYSE:TRUP)

Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.